Dr. Ryou received his MD degree from Harvard Medical School and completed advanced Clinical and Research fellowships at Brigham and Women’s Hospital and Massachusetts General Hospital, both teaching affiliates of Harvard Medical School. Dr. Ryou is currently a staff physician and advanced endoscopist at Brigham and Women’s Hospital, Harvard Medical School. Dr. Ryou has served as consultant to various medical device companies, including Covidien and Beacon Endoscopic, Inc. and he has founded GI Windows.
Chiara is an experienced Biomedical Engineer working in product development within the medical device sector. Since the company formation, Chiara led all technical activities and drove the technology to its current status. Chiara is working on optical sensors development and is responsible of expanding the current IP portfolio of the company. Chiara has previously worked in Vysera Biomedical as a R&D Engineer with particular emphasis on biomaterials for synthetic valves in GI and urology applications. In Vysera she has also led PulmoStent, a European wide project for the development of a viable tracheal stent. She received her MSc in Biomedical Engineer from the ULB (Belgium) and her MSc. In Nanotechnology and Tissue Engineering at the Politecnico of Milan.
Daragh is an experienced commercial MedTech executive who has many years of experience in driving commercial outcomes and success. Daragh has a Bsc from Trinity and a Masters in Business Technology. Daragh has completed a Diploma in International Sales management and has significant experience in establishing and managing Distribution networks across EU, USA and Asia.
Donal Devery is a serial entrepreneur and founder of EnteraSense. Previously as CEO of Vysera he is responsible for commercialization of the company’s technology. Mr. Devery has over 20 years of experience in product development and technology commercialization, in a variety of disciplines from small start-up companies to multinational corporations.
Based in Galway, Ireland we have a licensed technology agreement from Brigham and Women’s Hospital/Harvard Medical School which enables us to develop ground-breaking devices for diagnosing and monitoring Upper Gastric Bleeds.